Fujian Food and Drug Administration strengthens monitoring of adverse drug reactions

According to the relevant work arrangements and requirements of the State Food and Drug Administration and the General Office of the Provincial Government, in conjunction with the actual situation, the Fujian Food and Drug Administration formulated the “2012 Implementation Plan for Monitoring Adverse Drug Reactions”.

The first is to improve the province's adverse drug reaction monitoring and reporting system, expand its monitoring network, and further increase the number and quality of reports.

The second is to organize and carry out verification and evaluation work on dead and new and serious group adverse event reports, improve the emergency response capacity of adverse drug reactions (events), and actively explore emergency management mechanisms and routine monitoring mechanisms.

Third, through education, publicity, and training methods, the province's system for the monitoring of drugs, medical devices, and drug abusers has been improved in its safety monitoring capabilities and technical level.

Fourth, through the monitoring of essential medicines, key monitoring species, adverse events of drug and medical equipment, and monitoring of vaccine adverse reactions, the monitoring of adverse drug reactions and studies, and putting forward effective measures or regulations, timely detecting drug safety risks, and providing technical support for drug safety supervision.

Fifth, through the development of a monitoring network, we will carry out safety monitoring of medicines and drugs in the “old, young, border, island, and fishery” regions and accelerate the development of grass-roots monitoring systems.